Constantine Chinoporos is the Vice President, Global Business Development Licensing and is responsible for Sanofi’s global licensing function, having assumed that role in 2014. Additionally, the North American and European regional business development teams report to him. Constantine brings extensive experience in business development with nearly 20 years of working in external innovation-focused roles. He joined Sanofi following the Genzyme acquisition as the regional head of business development for Sanofi’s North American Pharmaceutical division. He assumed this role in December 2011. Prior to this position, he was a Vice President in Genzyme’s Corporate Development group, which he joined in 2001. Before Genzyme, Constantine served in various capacities at Eli Lilly and Company over a twelve year period, including roles in Corporate Finance and Investment Banking as well as the Office of Alliance Management. Constantine’s deal experience includes licensing, M&A, and product/business divestitures. Constantine received an undergraduate degree in history as well as an MBA from Cornell University.
E. Patrick Ellisen is an intellectual property lawyer in the Silicon Valley office of Orrick, Herrington & Sutcliffe LLP. Patrick focuses his practice on intellectual property protection, counseling and enforcement, and has wide-ranging experience in patent, trademark, copyright and trade secret matters. He has deep experience handling various types of intellectual property disputes, including patent infringement actions in the U.S. District Courts and before the U.S. International Trade Commission. Patrick regularly advises clients on intellectual property strategies and systems, negotiates and litigates intellectual property license agreements, and has unique experience in insurance coverage of intellectual property disputes. Patrick is a frequent lecturer on intellectual property management and best practices.
Jonathan Glass is the President & Co-Founder of Wise Labs, a pioneering business for connecting experienced scientists and engineers to a world that needs their inventive genius. Immediately prior to Wise Labs, Jon was the senior managing director for business development at GE Licensing, GE’s global technology, trademark and patent licensing business, and was responsible for executing strategic investments, building partnerships, developing new business models, and launching new companies around GE’s intellectual property assets. Jon previously served as a managing director at GE Equity, where he made strategic venture capital investments for GE, and has held multiple executive roles in deal originations, strategic marketing, new product development, portfolio management and underwriting across a range of industry sectors at GE Equity and GE Capital. Before joining GE, Jon was a consultant with Mercer Management Consulting, where he advised Fortune 500 clients in the technology, financial services and transportation sectors.
Matt Hulse is a Director of patent transactions at Intel Corporation and manages a team that handles patent assertion, patent acquisition, licensing, and related matters. He also runs Intel’s amicus brief program on intellectual property issues. He joined Intel in 2011 as senior litigation counsel and managed patent litigation matters, including through trial and appeal, at the U.S. International Trade Commission and various U.S. federal courts. He is also a registered patent attorney. Before joining Intel, he worked at Quinn Emanuel Urquhart & Sullivan, LLP, in Redwood Shores, California, where his practice focused on patent litigation matters. He received his law degree from the University of California, Berkeley, School of Law, where he served as an editor of the Berkeley Technology Law Journal and received a Certificate in Law and Technology. He also received a Bachelor of Science degree in mechanical engineering from Stanford University, with distinction. Before attending law school, he worked as a product support engineer at Applied Materials, Inc., a semiconductor equipment manufacturer, in Santa Clara, California.
David J. Kappos
David J. Kappos is a partner at Cravath. He is a leader in the field of intellectual property, including IP management and strategy, the development of global IP norms, laws and practices as well as commercialization and enforcement of innovation-based assets. From 2009 to 2013, Mr. Kappos served as Under Secretary of Commerce and Director of the U.S. Patent and Trademark Office (USPTO). In that role, he advised the President, Secretary of Commerce and the Administration on IP policy matters.
Mr. Kappos led the Agency in dramatically reengineering its entire management and operational systems and its engagement with the global innovation community. He was instrumental in achieving the greatest legislative reform of the U.S. patent system in generations through passage and implementation of the 2011 Leahy-Smith America Invents Act. Prior to leading the USPTO, Mr. Kappos served as IBM’s chief intellectual property lawyer from 2003 to 2009. In that capacity, he managed all global IP activities for IBM. During his more than 25 years at IBM, he also served in a variety of other roles including litigation counsel and Asia Pacific IP counsel, where he led all aspects of IP protection, including licensing, transactions support and M&A activity for the Asia/Pacific region.
Robert J. Kovacev
Robert J. Kovacev is a Tax Partner at Steptoe & Johnson LLP in Washington, DC. Prior to joining the firm in 2013, Mr. Kovacev was a senior litigation counsel in the United States Department of Justice, Tax Division, responsible for litigating some of the largest and most complex civil tax cases in the nation. Mr. Kovacev worked closely with the Internal Revenue Service’s Large Business & International Division to shape litigation strategy on high-priority tax enforcement issues.
Mr. Kovacev now represents taxpayers in complex tax matters including transfer pricing, intellectual
property valuation issues, and innovation tax incentives such as research credits, “green” energy credits,
and domestic production activities deductions. Mr. Kovacev has particular knowledge regarding the IRS’s
use of the economic substance doctrine to disallow the tax benefits of transactions that comply with the
technical requirements of the tax code.
Chuck Sholtz is Vice President, Intellectual Property at Coherus Biosciences, a “pure play” biosimilar platform company. His responsibilities include IP support for several Coherus pipeline products, including patent landscape analyses, patent portfolio development and management, and IP licensing. Prior to joining Coherus, Chuck served for eight years as Senior Counsel in the IP Law Group at Amgen, where he supported programs in both the innovator and biosimilar sides of the company. Before earning his law degree at Santa Clara University, he worked as a post-doctoral fellow in the Neurology Department at Massachusetts General Hospital and the Department of Genetics at Harvard Medical School. Chuck has Bachelor of Science degrees in Cellular and Molecular Biology and Engineering Science (Bioengineering) from the University of Michigan, a Masters in Physiology from Yale, and a Ph.D. in Neuroscience from Stanford.
Tony Smith has served as Vice President, Tax and Treasury, and Treasurer, for Thermo Fisher Scientific since 2004. He is responsible for the company’s global tax and treasury operations and pension investments. Mr. Smith has 20 years of experience in tax and treasury. Before joining Thermo Fisher, he was a partner at PricewaterhouseCoopers U.S. and U.K., and prior to that served as a partner at Pannell Kerr Forster in the U.K.
Mr. Smith holds a Bachelor of Science degree in Economics from Loughborough in the U.K. and is a U.K. Chartered Accountant
Niraja Srinivasan leads the Global Transfer Pricing function at Dell. In this capacity, she is responsible for transfer pricing planning, compliance, documentation and controversy. Niraja has worked as a transfer pricing economist for over 15 years. Prior to Dell, she spent eight years at General Electric in a number of business and corporate transfer pricing and valuation/M&A leadership roles. Niraja began her transfer pricing career at A.T. Kearney and then spent five years in PWC’s Chicago TP practice. She received her Ph.D. in applied economics in 1996 from the Wharton School. She holds certifications in business valuations and corporate finance. Niraja lives in Austin, TX.
- Alternative Asset Advisory
- Compliance and Regulatory Consulting
- Disputes and Investigations
- ESOP and ERISA Advisory
- Fairness Opinions
- Legal Management Consulting
- M&A Advisory
- Real Estate Advisory Group
- Restructuring Advisory
- Solvency Opinions
- Tax Services
- Transaction Advisory Service
- Transaction Opinions
- Consumer, Retail, Food and Restaurants
- Energy and Mining
- Financial Services and Asset Management
- Healthcare and Life Sciences
- Media and Entertainment
- Real Estate
- Technology and Telecom
- Alternative Assets
- Compliance and Regulatory
- Cost of Capital
- Disputes and Investigations
- Goodwill Impairment
- Legal Management
- Risk Premium
- Transfer Pricing
- Transaction Opinions
- Latin America
- U.S. / Canada